A research project led by the University of Utah (UT, USA) has reported a new method for reducing chronic pain by editing the epigenome. By modulating genes that reduce tissue- and cell-damaging inflammation, this therapy could hold promise for sufferers of chronic back and joint pain. The research was published in Tissue Engineering, in collaboration with Duke University (NC, USA) and Washington University in St. Louis (MO, USA).
Restricted Content / Members Only
You cannot view this content because It is available to members only. Please Login or Register to view this area.